Skip to main content

Levetiracetam

NDC 50405-300 · SOHM, Inc.

Generic nameLevetiracetam
Dosage formTABLET
RouteORAL
Active ingredient(s)LEVETIRACETAM
Strength250 mg/1
Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

50405-300-01 — 30 TABLET in 1 BOTTLE (50405-300-01)

50405-300-02 — 120 TABLET in 1 BOTTLE (50405-300-02)

50405-300-03 — 500 TABLET in 1 BOTTLE (50405-300-03)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-7774 — Levetiracetam, 50090-7775 — Levetiracetam, 50090-7804 — Levetiracetam, 50090-7820 — Levetiracetam, 50228-189 — levetiracetam, 50228-190 — levetiracetam, 50228-470 — Levetiracetam, 50228-471 — Levetiracetam, 50228-472 — Levetiracetam, 50228-473 — Levetiracetam, 50405-301 — Levetiracetam, 50405-302 — Levetiracetam, 50405-303 — Levetiracetam, 50474-001 — levetiracetam, 50474-002 — levetiracetam, 50474-594 — levetiracetam, 50474-595 — levetiracetam, 50474-596 — levetiracetam, 50474-597 — levetiracetam, 50474-598 — levetiracetam, +277 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels